FI850449A0 - Foerfarande foer framstaellning av (-) -trans-4-(4-fluorfenyl)-3-(4-metoxifenoxi)-metylpiperidin eller farmaceutiskt godtagbara syraadditionssalter daerav. - Google Patents

Foerfarande foer framstaellning av (-) -trans-4-(4-fluorfenyl)-3-(4-metoxifenoxi)-metylpiperidin eller farmaceutiskt godtagbara syraadditionssalter daerav.

Info

Publication number
FI850449A0
FI850449A0 FI850449A FI850449A FI850449A0 FI 850449 A0 FI850449 A0 FI 850449A0 FI 850449 A FI850449 A FI 850449A FI 850449 A FI850449 A FI 850449A FI 850449 A0 FI850449 A0 FI 850449A0
Authority
FI
Finland
Prior art keywords
methoxyphenoxy
methylpiperidine
fluorophenyl
trans
framstation
Prior art date
Application number
FI850449A
Other languages
English (en)
Other versions
FI850449L (fi
Inventor
Jorgen Buus Lassen
Jorgen Anders Christensen
Erling Niels Petersen
John Bondo Hansen
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan As filed Critical Ferrosan As
Publication of FI850449A0 publication Critical patent/FI850449A0/fi
Publication of FI850449L publication Critical patent/FI850449L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI850449A 1984-02-07 1985-02-04 Foerfarande foer framstaellning av (-) -trans-4-(4-fluorfenyl)-3-(4-metoxifenoxi)-metylpiperidin eller farmaceutiskt godtagbara syraadditionssalter daerav. FI850449L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/577,844 US4585777A (en) 1984-02-07 1984-02-07 (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT

Publications (2)

Publication Number Publication Date
FI850449A0 true FI850449A0 (fi) 1985-02-04
FI850449L FI850449L (fi) 1985-08-08

Family

ID=24310381

Family Applications (1)

Application Number Title Priority Date Filing Date
FI850449A FI850449L (fi) 1984-02-07 1985-02-04 Foerfarande foer framstaellning av (-) -trans-4-(4-fluorfenyl)-3-(4-metoxifenoxi)-metylpiperidin eller farmaceutiskt godtagbara syraadditionssalter daerav.

Country Status (12)

Country Link
US (1) US4585777A (fi)
EP (1) EP0152273B1 (fi)
JP (1) JPS60181071A (fi)
AT (1) ATE46146T1 (fi)
CA (1) CA1246082A (fi)
DE (1) DE3572807D1 (fi)
DK (1) DK53285A (fi)
ES (1) ES8601131A1 (fi)
FI (1) FI850449L (fi)
GR (1) GR850309B (fi)
IE (1) IE850286L (fi)
NO (1) NO850444L (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process
GB9700690D0 (en) 1997-01-15 1997-03-05 Smithkline Beecham Plc Novel process
IL133140A0 (en) * 1997-05-29 2001-03-19 Smithkline Beecham Corp Novel process for the preparation of 4-aryl-piperidines
AU2002301956B2 (en) * 1997-06-10 2006-02-09 Synthon B.V. 4-phenylpiperidine compounds
PT994872E (pt) * 1997-06-10 2001-09-28 Synthon Bv Composto de 4-fenilpiperidina
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
CZ20023694A3 (cs) 2000-05-12 2003-05-14 Synthon B. V. Tosylátové soli 4-(p-fluorfenyl)-piperidin-3-methanolů
US20040087795A1 (en) * 2000-07-17 2004-05-06 Borrett Gary Thomas Novel processes for the preparation of 4-phenylpiperidine derivatives
WO2002028834A1 (en) * 2000-10-06 2002-04-11 Smithkline Beecham P.L.C. Process for the preparation of aryl-piperidine carbinols and intermediates thereof
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
NL1017421C2 (nl) * 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
AU2002318185A1 (en) 2001-06-13 2002-12-23 Teva Pharmaceutical Industries Ltd. Process for the preparation of paroxetine substantially free of alkoxy impurities
US20070142389A1 (en) * 2005-12-20 2007-06-21 Pfizer Inc. Piperidine derivatives
EP2200997B9 (en) 2007-09-13 2016-01-13 Concert Pharmaceuticals Inc. Synthesis of deuterated benzodioxoles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds

Also Published As

Publication number Publication date
DK53285D0 (da) 1985-02-06
NO850444L (no) 1985-08-08
FI850449L (fi) 1985-08-08
IE850286L (en) 1985-08-07
ATE46146T1 (de) 1989-09-15
ES540172A0 (es) 1985-11-16
CA1246082A (en) 1988-12-06
EP0152273B1 (en) 1989-09-06
JPS60181071A (ja) 1985-09-14
DE3572807D1 (en) 1989-10-12
GR850309B (fi) 1985-06-05
JPS6135176B2 (fi) 1986-08-12
EP0152273A2 (en) 1985-08-21
US4585777A (en) 1986-04-29
ES8601131A1 (es) 1985-11-16
EP0152273A3 (en) 1986-12-30
DK53285A (da) 1985-08-08

Similar Documents

Publication Publication Date Title
FI850449A0 (fi) Foerfarande foer framstaellning av (-) -trans-4-(4-fluorfenyl)-3-(4-metoxifenoxi)-metylpiperidin eller farmaceutiskt godtagbara syraadditionssalter daerav.
NO174239C (no) Fremgangsmåte for fremstilling av et oralt, farmasöytisk preparat
NO873091L (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
FI892603A (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 4-(kinolin-2-yylimetoksi)fenyylietikkahappojohdannaisten valmistamiseksi
NO862861L (no) Fremgangsmaate for fremstilling av distamycinderivater.
YU45719B (sh) Postopek za pripravo mešano substituiranih enantiomerno čistih 1,2-diacil-sn-gli cero-3-fosfoholinov in 1,2-di-acil-sn-glicero-3-fosfoetanolaminov
IT8548267A0 (it) Derivati di i,4-diidropiridina e suoi sali, procedimento per produrli e composizione farmaceutica cheli contiene
PT87854A (pt) Process for the preparation of thio-urea derivatives
SE7904216L (sv) Di-o-n-alkylglycerolderivat med immunitetsstimulerande verkan
DE3577443D1 (de) Derivate von dihydroorotsaeure, deren verfahren zur herstellung und deren pharmazeutische zusammensetzungen.
IT8921894A0 (it) Procedimento per la produzione di impiallacciatura di radica artificiale mediante fogli di legno rigati.
PT87359A (pt) Process for the preparation of pyrrolidine derivatives
NO872574L (no) FremgangsmŸte for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler.
NO872393D0 (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
DK89289A (da) Anvendelse af 1,4-dihydropyridin-derivater til fremstilling af laegemiddel til afvaenning af alkoholister
NO864525D0 (no) Fremgangsmaate ved fremstilling av aryleddiksyrederivater.
IT8621066A0 (it) Procedimento per la preparazione di composti eterociclici azotati.
NO852796L (no) Fremgangsmaate for fremstilling av nitroapovincamin-syrederivater.
SE8500822D0 (sv) Diazepinoindoles, their production and pharmaceutical compositions containing them
AT375938B (de) Verfahren zur herstellung von 9-amino-6,7-dihydro-4h-pyrido (1,2-a) pyrimidin-4-on-derivaten, deren physiologisch vertraeglichen salzen, hydraten und isomeren
NO884442D0 (no) Fremgangsmaate for fremstilling av 3,3-disubstituerte indoliner.
DE3676116D1 (de) Herstellung von azetidin-derivaten.
FR2585354B1 (fr) Procede stereoselectif de preparation de derives de la proline
NO882493L (no) Fremgangsmaate for fremstillng av kinolincarboxylsyrederivater.
ATE36314T1 (de) Verfahren zur herstellung von alpha,alphadifluoralkyl-phenylaether-derivaten.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: A/S FERROSAN